Monthly Archives: October 2025

Health Canada has recently approved Rinvoq (upadacitinib) for adults living with Giant Cell Arteritis (GCA). Rinvoq is the first and only once-daily, non-steroidal pill approved to treat this condition. GCA causes inflammation in blood vessels, often leading to headaches, jaw pain, or … Continue reading →

Every year on October 12, World Arthritis Day raises awareness about the millions of people living with arthritis and related joint conditions. In Canada alone, more than 6 million people are affected by some form of arthritis. The most common … Continue reading →